RT @MyHarmReduction: The pharmaceutical industry is a huge finder of peer-reviewed journals in medicine and psychiatry through advertising.…
"Few physician-directed print pharmaceutical advertisements adhere to all FDA guidelines; over half fail to quantify serious risks" https://t.co/iWShp8OYUG
The pharmaceutical industry is a huge finder of peer-reviewed journals in medicine and psychiatry through advertising. And those ads often lie https://t.co/1q7fGE09JA
RT @jsross119: As we've shown in a couple of studies of journal ads to physicians (https://t.co/klxQ3pc1Y3) and direct-to-consumer televisi…
RT @jsross119: As we've shown in a couple of studies of journal ads to physicians (https://t.co/klxQ3pc1Y3) and direct-to-consumer televisi…
As we've shown in a couple of studies of journal ads to physicians (https://t.co/klxQ3pc1Y3) and direct-to-consumer television ads (https://t.co/4PKvI3UZWa) @JournalGIM @PLOSONE
RT @jsross119: @drJoshS @Yale_CRIT @AmeetSarpatwari @LJA_Foundation @VinayPrasad82 @gregggonsalves @DKorenstein The more things change, the…
@drJoshS @Yale_CRIT @AmeetSarpatwari @LJA_Foundation @VinayPrasad82 @gregggonsalves @DKorenstein The more things change, the more they stay the same ... @DKorenstein and I looked at journal ads too, in 2011 https://t.co/klxQ3pc1Y3; we tried to study magazi
And ads rarely adhere to @US_FDA guidelines, fail to adequately disclose risk, efficacy http://t.co/klxQ3pc1Y3 https://t.co/19CUobZlw7
And ads rarely adhere to @US_FDA guidelines, fail to adequately disclose risk, efficacy http://t.co/klxQ3pc1Y3 https://t.co/19CUobZlw7
And ads rarely adhere to @US_FDA guidelines, fail to adequately disclose risk, efficacy http://t.co/klxQ3pc1Y3 https://t.co/19CUobZlw7
Rarely happens: @US_FDA issues warning letter about Rx ad superiority claim http://t.co/gN5OzVMHcK but freq happens: http://t.co/VXBYHh9yoR
Rarely happens: @US_FDA issues warning letter about Rx ad superiority claim http://t.co/gN5OzVMHcK but freq happens: http://t.co/VXBYHh9yoR
Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing. http://t.co/k1XBZrqB
Adherence of Pharmaceutical Ads in Med Journals to #FDA Guidelines & Content for Safe Prescribing http://ht.ly/6g6HE
Over half of print pharmaceutical advertisements fail to quantify serious risks. Full text. http://t.co/IYVyBY8
Over half of print pharmaceutical advertisements fail to quantify serious risks. Full text. http://t.co/i2oAhFt
Over half of print pharmaceutical advertisements fail to quantify serious risks. Full text. http://t.co/GWp73td
RT @SIETES7: Sobre anuncios de medicamentos y sus mentiras. Plos One http://ow.ly/6iq27
RT @SIETES7: Sobre anuncios de medicamentos y sus mentiras. Plos One http://ow.ly/6iq27
RT @SIETES7: Sobre anuncios de medicamentos y sus mentiras. Plos One http://ow.ly/6iq27
STUDY: Only 18% of #Pharma journal ads compliant with FDA guidelines http://t.co/hqD1lC9
PLoS One Study: Most Medical Journal Print Drug Ads Ignore FDA Risk Reporting Guidelines #ptsafety #bioethics #HAchat http://t.co/P5b2rue
Medical Journals Fail FDA Guidelines (Content for Safe Prescribing) On Pharmaceutical Advertisements ($$$). http://t.co/aRl7Z3s
RT @ARAC100: RT @maureenshaffer @GPPnews: Promotional review checklist from @MountSinaiNYC @WeillCornell @YaleMed (Table & Figure S1) http://ow.ly/66z3t
PLoS ONE: Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines: http://t.co/yBKFSIK via @addthis
RT @DigitalBulldog: New study reviews Pharma journal ads adherence with FDA guidelines - most non-compliant http://t.co/a7BZZPz
RT @MedDeviceMark: Article in PLoS ONE says most pharma ads in journals would flunk review by FDA's Div. of Drug Marketing, Adv, and Comm http://t.co/P4WoRKo
RT @PLoSMedicine: #PLoS ONE: Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines a... http://t.co/DH0mZ7V
RT @SurvivingADs: Pharma advertising: Study finds few ads adhere to FDA guidelines, "over half fail to quantify serious risks" http://t.co/rvkEPK0
RT @PLoSMedicine: #PLoS ONE: Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines a... http://t.co/DH0mZ7V
Pharma advertising: Study finds few ads adhere to FDA guidelines, "over half fail to quantify serious risks" http://t.co/rvkEPK0
#PLoS ONE: Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines a... http://t.co/DH0mZ7V
RT @cardiobrief: MT @charlesornstein: Study finds majority of pharmaceutical ads do not adhere to FDA guidelines PLoS one: http://t.co/OyFXzF2
#PLoS: Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines a... http://t.co/rckn0Hx
Few physician-directed print pharmaceutical advertisements adhere to all FDA guidelines;over 1/2 fail to quantify.. http://t.co/b1zYPWh
RT @maureenshaffer @GPPnews: Promotional review checklist from @MountSinaiNYC @WeillCornell @YaleMed (Table & Figure S1) http://ow.ly/66z3t
RT @charlesornstein: Study finds majority of pharmaceutical ads do not adhere to FDA guidelines. Over 1/2 fail to quantify serious risks http://t.co/wIs5Opd
RT @gppnews: Promotional material review checklist from @MountSinaiNYC @WeillCornell @YaleMed (Table & Figure S1) http://ow.ly/66z3t...
RT @WendyBlackburn: @FDALawyers http://t.co/UfdNazT I'd never heard of the journal: Bias watch: PLOS takes no advertising!
@FDALawyers http://t.co/MB6KWpT I'd never heard of the journal
MT @charlesornstein: Study finds majority of pharmaceutical ads do not adhere to FDA guidelines PLoS one: http://t.co/OyFXzF2
RT @charlesornstein: Study finds majority of pharmaceutical ads do not adhere to FDA guidelines. Over 1/2 fail to quantify serious risks http://t.co/wIs5Opd
RT @charlesornstein: Study finds majority of pharmaceutical ads do not adhere to FDA guidelines. Over 1/2 fail to quantify serious risks http://t.co/wIs5Opd
Study finds majority of pharmaceutical ads do not adhere to FDA guidelines. Over 1/2 fail to quantify serious risks http://t.co/wIs5Opd